In the eye of the cytokine storm: High-grade antibodies, proteins and ELISAs
12 February 2021

Severe COVID-19 patients have shown to exhibit a higher concentration of pro-inflammatory cytokines. The study of Cytokine Release Syndrome (CRS) has become increasingly important in exploring potential therapeutic treatment options for coronavirus patients. 

Leinco Technologies is committed to providing necessary tools to researchers as they investigate and discover critical new information on COVID-19 and Cytokine Storm detection and prevention. 

     Page  1 Next 
COVID-19 ImmunoRank™ Neutralization MICRO-ELISA9 Sep 2020